Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Syncona (SYNC) Share Price

Price 122.00p on 01-10-2026 at 17:55:09
Change -1.80p -1.45%
Buy 123.00p
Sell 122.00p
Last Trade: Sell 1,970.00 at 122.00p
Day's Volume: 232,280
Last Close: 122.00p
Open: 123.60p
ISIN: GG00B8P59C08
Day's Range 122.00p - 123.60p
52wk Range: 86.90p - 124.00p
Market Capitalisation: £742.01m
VWAP: 122.89065p
Shares in Issue: 608.20m

Syncona (SYNC) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 1,970 122.00p Automatic Execution
16:35:09 - 01-Oct-26
Sell* 23,246 122.00p Uncrossing Trade
16:35:09 - 01-Oct-26
Sell* 84 122.00p Automatic Execution
16:29:54 - 01-Oct-26
Sell* 21 122.00p Automatic Execution
16:29:54 - 01-Oct-26
Sell* 425 122.00p Automatic Execution
16:29:53 - 01-Oct-26
Sell* 1 122.00p Automatic Execution
16:18:14 - 01-Oct-26
Sell* 818 122.08p Ordinary
15:40:55 - 01-Oct-26
Sell* 858 122.40p Automatic Execution
15:35:34 - 01-Oct-26
Sell* 62 122.40p Automatic Execution
15:35:34 - 01-Oct-26
Sell* 9,296 122.60p Automatic Execution
15:35:34 - 01-Oct-26
See more Syncona trades

Syncona (SYNC) Share Price History

Time period:
to
Date Open High Low Close Volume
1st Oct 2026 (Thu) 123.60 123.60 122.00 122.00 232,280
30th Sep 2026 (Wed) 123.00 123.80 123.00 123.80 304,937
29th Sep 2026 (Tue) 123.00 124.00 122.20 122.40 312,263
28th Sep 2026 (Mon) 123.00 123.00 122.20 122.20 336,420
25th Sep 2026 (Fri) 118.40 124.00 118.00 122.00 5,496,911
24th Sep 2026 (Thu) 117.80 118.40 117.60 117.80 559,496
23rd Sep 2026 (Wed) 119.00 119.00 117.40 117.80 2,086,234
22nd Sep 2026 (Tue) 119.00 119.00 116.00 116.00 12,408,582
21st Sep 2026 (Mon) 114.20 120.20 114.20 117.40 35,993,657
18th Sep 2026 (Fri) 113.80 115.00 111.60 111.60 561,621
17th Sep 2026 (Thu) 112.00 112.00 111.60 111.80 245,813
16th Sep 2026 (Wed) 111.40 112.80 111.40 111.60 298,511
15th Sep 2026 (Tue) 113.80 113.80 112.40 113.60 34,069
14th Sep 2026 (Mon) 112.60 114.40 111.00 112.00 221,047
11th Sep 2026 (Fri) 111.20 112.60 111.20 112.60 103,134
10th Sep 2026 (Thu) 111.00 112.20 111.00 111.20 330,440
9th Sep 2026 (Wed) 111.00 111.20 111.00 111.00 434,677
8th Sep 2026 (Tue) 112.40 112.40 111.00 111.20 301,977
7th Sep 2026 (Mon) 114.80 114.80 112.40 113.00 335,271
4th Sep 2026 (Fri) 113.40 113.60 112.00 112.80 301,548
3rd Sep 2026 (Thu) 113.40 113.40 112.80 112.80 480,629
2nd Sep 2026 (Wed) 116.00 116.00 113.20 113.20 375,690
See more Syncona price history

Syncona (SYNC) Regulatory News

Date Source Headline
29th Sep 2026 7:00 am RNS-R SIML announces changes to leadership team
24th Sep 2026 12:00 pm RNS Holding(s) in Company
23rd Sep 2026 8:30 am RNS Holding(s) in Company
21st Sep 2026 7:00 am RNS Beacon delivers positive topline PII/III results
17th Sep 2026 4:30 pm RNS Holding(s) in Company
11th Sep 2026 3:15 pm RNS Holding(s) in Company
25th Aug 2026 5:15 pm RNS Holding(s) in Company
21st Aug 2026 8:00 am RNS Holding(s) in Company
18th Aug 2026 11:05 am RNS Result of AGM
6th Aug 2026 7:00 am RNS First Quarter Update
See more Syncona regulatory news

Syncona (SYNC) Share News

WINNERS & LOSERS: US-China optimism supports miners; Syncona up

21st Sep 2026 10:32

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday. Read More

IN BRIEF: Syncona says Beacon passes test in preventing vision loss

21st Sep 2026 08:58

Syncona Ltd - London-based life science investor - Portfolio holding Beacon Therapeutics Ltd's gene therapy laru-zova meets its primary endpoint in a phase II/III trial in treating the blinding condition X-linked retinitis pigmentosa. The endpoint, which was endorsed by the US Food & Drug Administration, was demonstrating statistically significant low luminesce visual acuity in patients at month 12, compared to a control group. XLRP is an inherited retinal disease that leads to progressive vision loss, moving from night blindness to being legally blind. Following the test results, Beacon plans a rolling biologics license application submission later this year. Read More

WINNERS & LOSERS: Vistry surges on UK government funding boost

25th Aug 2026 10:19

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

UK shareholder meetings calendar - next 7 days

11th Aug 2026 13:48

Read More

FTSE 250 EARNINGS & UPDATES: TBC Bank profits from Georgian economy

6th Aug 2026 14:28

(Alliance News) - The following is a round-up of earnings and trading updates by FTSE 250-listed London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

See more Syncona news
FTSE 100 Latest
Value10,428.27
Change-177.73

Login to your account

Forgot Password?

Not Registered